M Bluett-Duncan, D Astill, R Charbak, J Clayton-Smith, S Cole, P A Cook, J Cozens, K Keely, J Morris, R Mukherjee, E Murphy, P Turnpenny, J Williams, A G Wood, L M Yates, R L Bromley
AIM: To describe the neurodevelopmental phenotype of older children and adults with a diagnosis of Fetal Valproate Spectrum Disorder (FVSD). METHODS: In this cross-sectional study, 90 caregivers were recruited and completed a series of questionnaires regarding the neurodevelopmental outcomes of 146 individuals aged 7-37 years (M = 18.1), including individuals with a formal diagnosis of FVSD (n = 99), individuals exposed to Valproate but without an FVSD diagnosis (n = 24), and individuals not exposed to Valproate (N = 23)...
September 2, 2023: Neurotoxicology and Teratology